Learn more

ANTARES PHARMA IPL AG

Overview
  • Total Patents
    85
  • GoodIP Patent Rank
    221,713
About

ANTARES PHARMA IPL AG has a total of 85 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, machines and measurement are HEALTH MAINTENANCE PROGRAMS, SHIRE LAB INC and MEPHA AG.

Patent filings per year

Chart showing ANTARES PHARMA IPL AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Grenier Arnaud 50
#2 Carrara Dario Norberto R 36
#3 Besse Celine 32
#4 Lehman Leah M 23
#5 Simes Stephen M 22
#6 Porto Gabriel 12
#7 Rodriguez Jorge 12
#8 Carrara Dario 12
#9 Sadowski Peter L 9
#10 Kraus Holger 8

Latest patents

Publication Filing date Title
US2015005337A1 Transdermal Delivery Of Systemically Active Central Nervous System Drugs
US2014037713A1 Transdermal compositions for anti-cholinergic agents
US2011195114A1 Transdermal delivery systems for active agents
AU2010339867A1 Nestorone/estradiol transdermal gel
NZ585278A Metered gel dispenser with concave applicator for skin contact
WO2008067991A2 Skin-friendly drug complexes for transdermal administration
WO2008012071A2 Pharmaceutical compositions of nicotine and methods of use thereof
WO2008001204A2 Transdermal compositions of pramipexole having enhanced permeation properties
WO2008001200A2 Transdermal composition having enhanced color stability
CN101426475A Methods of treating hot flashes with formulations for transdermal or transmucosal application
MX2008013207A Methods of treating hot flashes with formulations for transdermal or transmucosal application.
WO2007093305A2 Low-friability, patient-friendly orally disintegrating formulations
EP1928406A2 Pharmaceutical compositions with melting point depressant agents and method of making same
US7387788B1 Pharmaceutical compositions of nicotine and methods of use thereof
WO2006125642A1 Methods and apparatus for transdermal or transmucosal application of testosterone
US2005287194A1 Permeation enhancing compositions for anticholinergic agents
WO2005105059A1 Permeation enhancer comprising genus curcuma or germacrone for transdermal and topical administration of active agents
MXPA06003316A Transdermal pharmaceutical formulation for minimizing skin residues.
CN1997357A Uses and formulations for transdermal or transmucosal application of active agents
BRPI0408153A formulations for transdermal or transmucosal administration of active agent, methods of treating individual hormone disorders, use of formulation and permeation enhancer, and kit for treating individual